Skip to content
DraconiticResearch
Search Sources API
220,430 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BY 4.0Cureus

Relationship Between Serum Magnesium Levels and Glycemic Control in Type 2 Diabetes Mellitus: A Case-Control Study

  1. 1Internal Medicine, Azeezia Institute of Medical Sciences and Research, Kollam, IND
  2. 2Internal Medicine, Sree Uthradom Thiurnal (SUT) Academy of Medical Sciences, Thiruvananthapuram, IND
  3. 3Pathology, Government Medical College, Thrissur, IND

Abstract

Introduction: Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder that represents a global health burden. Recent findings indicate that serum magnesium plays a crucial role in glucose metabolism and insulin function. Insufficient magnesium levels are associated with diminished insulin secretion and increased insulin resistance. However, region-specific data from South India, particularly Kerala, remain limited.

Materials and methods: A case-control study was conducted in the Department of Medicine of a tertiary care hospital in Kerala from November 2022 to March 2024 to compare serum magnesium levels between adults with uncontrolled and controlled T2DM and to assess the associations of serum magnesium levels with HbA1c and other clinical and biochemical variables. A total of 34 patients with uncontrolled T2DM (HbA1c >7%) and 34 patients with controlled T2DM (HbA1c ≤7%), classified according to the 2021 American Diabetes Association glycemic target guidelines, were matched by age and sex. Demographic and laboratory data were analyzed using SPSS Statistics version 25 (IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY), with p < 0.05 considered statistically significant.

Results: Demographic characteristics were similar across groups. Uncontrolled cases had significantly higher HbA1c (median 8.3%, IQR 7.83-9.0 vs 6.7%, IQR 6.5-6.9; p < 0.001), fasting blood sugar (median 187.5, IQR 142-204 vs 120 mg/dL, IQR 110.25-131.75; p < 0.001), and blood pressure than controls. Hypomagnesemia occurred only in patients with uncontrolled T2DM (5/34, 14.7%); median serum magnesium was significantly lower in cases than in controls (2.1, IQR 1.9-2.3 vs 2.3 mg/dL, IQR 2.1-2.3; p = 0.018). Within cases, serum magnesium correlated inversely with triglycerides (ρ = −0.417, p = 0.014) but not significantly with HbA1c (ρ = −0.196, p = 0.266).

Conclusions: Serum magnesium was lower in uncontrolled than in controlled T2DM, with hypomagnesemia only in the uncontrolled group. Within cases, magnesium correlated inversely with triglycerides but not significantly with HbA1c. Causality cannot be established given the design; larger prospective and interventional studies are needed.

Related

  1. Chronic Proton Pump Inhibitor Use and Glycemic Control in Older Adults with Type 2 Diabetes Mellitus: A Retrospective Cross-Sectional Study
    Safiye Kübra Çetindağ Karatlı, Hatice Ergin, Merve Duygu Yurtbay +1
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Association Between Left Atrial Volume Index (LAVI) and Glycemic Control (HbA1c) in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus
    Marvelous O Popoola, Muhammad Abbas Shahid, Faiq Aftab +7
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Exploring Predictive Modeling Algorithms for Good Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Secondary Analysis of a Cluster Randomized Trial Cohort Further Explored by Sex
    Sana Shan, Antonio Michell, Angela Xun‐Nan Chen +7
    Health science reportsPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Glycemic Control and Associated Factors Among Children With Type 1 Diabetes Mellitus at the Pediatric Diabetic Clinic of Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia
    Mekashaw Wudu, Senbeto Gehano, Minase Shenkute +1
    Journal of Diabetes ResearchPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismPMC
  5. Poor sleep quality and anxiety in patients with diabetes mellitus and its association with glycemic control: A cross-sectional study
    Wissal Baghdad, Amal Satté, Otmane El Harrati +9
    PLOS OnePeer-reviewedCC BYFull textEndocrinology & metabolismPsychiatry & mental healthPLOSEurope PMC
BibTeX
@article{rahiman2026relationship,
  title = {{Relationship Between Serum Magnesium Levels and Glycemic Control in Type 2 Diabetes Mellitus: A Case-Control Study}},
  author = {Shahina Abdul Rahiman and Ganga Sanjeev and Gayathri Prathap and Gayathry Rajasekharan and Rajasekharan Chandrasekharan},
  journal = {Cureus},
  year = {2026},
  month = oct,
  doi = {10.7759/cureus.117718},
  url = {https://doi.org/10.7759/cureus.117718},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Relationship Between Serum Magnesium Levels and Glycemic Control in Type 2 Diabetes Mellitus: A Case-Control Study
AU  - Shahina Abdul Rahiman
AU  - Ganga Sanjeev
AU  - Gayathri Prathap
AU  - Gayathry Rajasekharan
AU  - Rajasekharan Chandrasekharan
PY  - 2026
DA  - 2026/10/10
JO  - Cureus
DO  - 10.7759/cureus.117718
UR  - https://doi.org/10.7759/cureus.117718
AB  - Introduction: Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder that represents a global health burden. Recent findings indicate that serum magnesium plays a crucial role in glucose metabolism and insulin function. Insufficient magnesium levels are associated with diminished insulin secretion and increased insulin resistance. However, region-specific data from South India, particularly Kerala, remain limited.  Materials and methods: A case-control study was conducted in the Department of Medicine of a tertiary care hospital in Kerala from November 2022 to March 2024 to compare serum magnesium levels between adults with uncontrolled and controlled T2DM and to assess the associations of serum magnesium levels with HbA1c and other clinical and biochemical variables. A total of 34 patients with uncontrolled T2DM (HbA1c >7%) and 34 patients with controlled T2DM (HbA1c ≤7%), classified according to the 2021 American Diabetes Association glycemic target guidelines, were matched by age and sex. Demographic and laboratory data were analyzed using SPSS Statistics version 25 (IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY), with p < 0.05 considered statistically significant.  Results: Demographic characteristics were similar across groups. Uncontrolled cases had significantly higher HbA1c (median 8.3%, IQR 7.83-9.0 vs 6.7%, IQR 6.5-6.9; p < 0.001), fasting blood sugar (median 187.5, IQR 142-204 vs 120 mg/dL, IQR 110.25-131.75; p < 0.001), and blood pressure than controls. Hypomagnesemia occurred only in patients with uncontrolled T2DM (5/34, 14.7%); median serum magnesium was significantly lower in cases than in controls (2.1, IQR 1.9-2.3 vs 2.3 mg/dL, IQR 2.1-2.3; p = 0.018). Within cases, serum magnesium correlated inversely with triglycerides (ρ = −0.417, p = 0.014) but not significantly with HbA1c (ρ = −0.196, p = 0.266).  Conclusions: Serum magnesium was lower in uncontrolled than in controlled T2DM, with hypomagnesemia only in the uncontrolled group. Within cases, magnesium correlated inversely with triglycerides but not significantly with HbA1c. Causality cannot be established given the design; larger prospective and interventional studies are needed.
SN  - 2168-8184
ER  -